Vol. 23 No. 2 (2019)
REVIEWS

Assessment of the predictors of persistence/progression of functional mitral insufficiency in patients undergoing the interventional treatment of aortic valve diseases

PDF (Русский)
  • I. Skopin,
  • I. Slivneva,
  • M. Latyshev,
  • D. Murysova,
  • T. Asatryan,
  • N. Sokolskaya,
  • A. Vavilov,
  • N. Toporkov
I. Skopin
A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russian Federation
I. Slivneva
A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russian Federation
Bio
M. Latyshev
A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russian Federation
D. Murysova
A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russian Federation
T. Asatryan
A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russian Federation
N. Sokolskaya
A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russian Federation
A. Vavilov
A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russian Federation
N. Toporkov
A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russian Federation
DOI: https://doi.org/10.21688/1681-3472-2019-2-9-19

Published 2019-10-15

Keywords

  • aortic stenosis,
  • aortic valve disease,
  • functional mitral regurgitation,
  • transcatheter aortic valve replacement

How to Cite

Skopin, I., Slivneva, I., Latyshev, M., Murysova, D., Asatryan, T., Sokolskaya, N., Vavilov, A., & Toporkov, N. (2019). Assessment of the predictors of persistence/progression of functional mitral insufficiency in patients undergoing the interventional treatment of aortic valve diseases. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 23(2), 9–19. https://doi.org/10.21688/1681-3472-2019-2-9-19

Copyright (c) 2019 Skopin I. I., Slivneva I. V., Latyshev M. S., Murysova D. V., Asatryan T. V., Sokolskaya N. O., Vavilov A. V., Toporkov N. O.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Mitral insufficiency usually accompanies numerous aortic valve diseases. At present, concomitant pronounced mitral regurgitation remains a fairly urgent problem in the transcatheter treatment of aortic valve diseases. During the postoperative period of transcatheter aortic valve replacement, mitral insufficiency tends to decrease in majority of the patients; however, in certain patients, mitral insufficiency persists as well as progresses, highlighting the advantages of this approach over open two-valve surgery. This article presents an analysis of research devoted to functional mitral insufficiency in patients undergoing the interventional treatment of aortic valve diseases. This study included high-risk patients (according to the STS scale of operational risk ≥8%), representing an older age group with a broad spectrum of comorbid pathologies. Some cases were categorised as the New York Heart Association functional class IV, presented with pronounced systolic dysfunction of the left ventricle or were considered inoperable. Based on the systematic review of eight studies, predictors of potential mitral insufficiency progression were identified, and treatment algorithms for this category of patients were studied for the interventional treatment of aortic valve disease. The intervention aims to optimise long-term prognosis, both in open surgery and minimally invasive interventions. The results of the present study will help improve immediate and long-term postoperative outcomes of the interventional treatment of aortic valve diseases. Determining the prognostic development of mitral regurgitation will help select the best management tactics for this complex group of patients, thereby improving treatment outcomes and long-term prognosis of both open surgery and minimally invasive interventions.

Received 26 June 2019. Revised 23 August 2019. Accepted 26 August 2019.

Funding: The study did not have sponsorship.

Conflict of interest: Authors declare no conflict of interest.

PDF (Русский)

References

  1. Waisbren E.C., Stevens L.M., Avery E.G., Picard M.H., Vlahakes G.J., Agnihotri A.K. Changes in mitral regurgitation after replacement of the stenotic aortic valve. Ann Thorac Surg. 2008;86(1):56-62. PMID: 18573398. https://doi.org/10.1016/j.athoracsur.2008.03.027
  2. Tunick P.A., Gindea A., Kronzon I. Effect of aortic valve replacement for aortic stenosis on severity of mitral regurgitation. Am J Cardiol. 1990;65(18):1219-21. PMID: 2337031. https://doi.org/10.1016/0002-9149(90)90977-9
  3. Adams P.B., Otto C.M. Lack of improvement in coexisting mitral regurgitation after relief of valvular aortic stenosis. Am J Cardiol. 1990;66(1):105-7. PMID: 2141754. https://doi.org/10.1016/0002-9149(90)90746-n
  4. Barreiro C.J., Patel N.D, Fitton T.P., Williams J.A., Bonde P.N., Chan V., Alejo D.E., Gott V.L., Baumgartner W.A. Aortic valve replacement and concomitant mitral valve regurgitation in the elderly: impact on survival and functional outcome. Circulation. 2005;112(9 Suppl):I443-7. PMID: 16159860. https://doi.org/10.1161/CIRCULATIONAHA.104.526046
  5. Ruel M., Kapila V., Price J., Kulik A., BurwashI G., Mesana T.G. Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement. Circulation. 2006;114(1 Suppl):I541-6. PMID: 16820634. https://doi.org/10.1161/CIRCULATIONAHA.105.000976
  6. Gilard M., Eltchaninoff H., Iung B., Donzeau-Gouge P., Chevreul K., Fajadet J., Leprince P., Leguerrier A., Lievre M., Prat A., Teiger E., Lefevre T., Himbert D., Tchetche D., Carrié D., Albat B., Cribier A., Rioufol G., Sudre A., Blanchard D., Collet F., Dos Santos P., Meneveau N., Tirouvanziam A., Caussin C., Guyon P., Boschat J., Le Breton H., Collart F., Houel R., Delpine S., Souteyrand G., Favereau X., Ohlmann P., Doisy V., Grollier G., Gommeaux A., Claudel J.P., Bourlon F., Bertrand B., Van Belle E., Laskar M.; FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366(18):1705-15. PMID: 22551129. https://doi.org/10.1056/NEJMoa1114705
  7. Leon M.B., Smith C.R., Mack M., Miller D.C., Moses J.W., Svensson L.G., Tuzcu E.M., Webb J.G., Fontana G.P., Makkar R.R., Brown D.L., Block P.C., Guyton R.A., Pichard A.D., Bavaria J.E., Herrmann H.C., Douglas P.S., Petersen J.L., Akin J.J., Anderson W.N., Wang D., Pocock S.; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-1607. PMID: 20961243. https://doi.org/10.1056/NEJMoa1008232
  8. De Chiara B., Moreo A., De Marco F., Musca F., Oreglia J., Lobiati E., Bruschi G., Belli O., Mauri F., Klugmann S. Influence of CoreValve revalving system implantation on mitral valve function: an echocardiographic study in selected patients. Catheter Cardiovasc Interv. 2011;78(4):638-44. https://doi.org/10.1002/ccd.23045
  9. Toggweiler S., Boone R.H., Rodés-Cabau J., Humphries K.H., Lee M., Nombela-Franco L., Bagur R., Willson A.B., Binder R.K., Gurvitch R., Grewal J., Moss R., Munt B., Thompson C.R., Freeman M., Ye J., Cheung A., Dumont E., Wood D.A., Webb J.G. Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation. J Am Coll Cardiol. 2012;59(23):2068-74. PMID: 22483326. https://doi.org/10.1016/j.jacc.2012.02.020
  10. Hekimian G., Detaint D., Messika-Zeitoun D., Attias D., Iung B., Himbert D., Brochet E., Vahanian A. Mitral regurgitation in patients referred for transcatheter aortic valve implantation using the Edwards Sapien prosthesis: mechanisms and early postprocedural changes. J Am Soc Echocardiogr. 2012;25(2):160-5. PMID: 22071307. https://doi.org/10.1016/j.echo.2011.10.001
  11. Cortés C., Amat-Santos I.J., Nombela-Franco L., Muñoz-Garcia A.J., Gutiérrez-Ibanes E., De La Torre Hernandez J.M., Córdoba-Soriano J.G., Jimenez-Quevedo P., Hernández-García J.M., Gonzalez-Mansilla A., Ruano J., Jimenez-Mazuecos J., Castrodeza J., Tobar J., Islas F., Revilla A., Puri R., Puerto A., Gómez I., Rodés-Cabau J., San Román J.A. Mitral regurgitation after transcatheter aortic valve replacement: prognosis, imaging predictors, and potential management. JACC Cardiovasc Interv. 2016;9(15):1603-14. PMID: 27491611. https://doi.org/10.1016/j.jcin.2016.05.025
  12. Mavromatis K., Thourani V.H., Stebbins A., Vemulapalli S., Devireddy C., Guyton R.A., Matsouaka R., Ghasemzadeh N., Block P.C., Leshnower B.G., Stewart J.P., Rumsfeld J.S., Lerakis S., Babaliaros V. Transcatheter aortic valve replacement in patients with aortic stenosis and mitral regurgitation. Ann Thorac Surg. 2017;104(6):1977-1985. PMID: 28965619. https://doi.org/10.1016/j.athoracsur.2017.05.065
  13. Shibayama K., Mihara H., Berdejo J., Harada K., Siegel R.J., Makkar R.R., Shiota T. Association of postprocedural aortic regurgitation with mitral regurgitation worsened after transcatheter aortic valve replacement. Echocardiography. 2018;35(3):346-52. PMID: 29272553. https://doi.org/10.1111/echo.13780
  14. Chiche O., Rodés-Cabau J., Campelo-Parada F., Freitas-Ferraz A.B., Regueiro A., Chamandi C., Rodriguez-Gabella T., Côté M., DeLarochellière R., Paradis J.M., Dumont E., Doyle D., Mohammadi S., Bergeron S., Pibarot P., Beaudoin J. Significant mitral regurgitation in patients undergoing TAVR: Mechanisms and imaging variables associated with improvement. Echocardiography. 2019;36(4):722-31. https://doi.org/10.1111/echo.14303
  15. Abdelghani M., Abdel-Wahab M., Hemetsberger R., Landt M., Merten C., Toelg R., Richardt G. Fate and long-term prognostic implications of mitral regurgitation in patients undergoing transcatheter aortic valve replacement. Int J Cardiol. 2019;288:39-43. PMID: 30948219. https://doi.org/10.1016/j.ijcard.2019.03.048
  16. León Del Pino C., Ruíz Ortiz M., Delgado Ortega M., Sánchez Fernández J., Ferreiro Quero C., Durán Jiménez E., Romero Moreno M., Segura Saint-Gerons J., Ojeda Pineda S., Pan Álvarez-Ossorio M., Mesa Rubio D. Prosthesis-patient mismatch after transcatheter aortic valve replacement: prevalence and medium term prognostic impact. Int J Cardiovasc Imaging. 2019;35(5):827-36. PMID: 30661140. https://doi.org/10.1007/s10554-018-01519-z
  17. Mack M.J., Leon M.B., Smith C.R., Miller D.C., Moses J.W., Tuzcu E.M., Webb J.G., Douglas P.S., Anderson W.N., Blackstone E.H., Kodali S.K., Makkar R.R., Fontana G.P., Kapadia S., Bavaria J., Hahn R.T., Thourani V.H., Babaliaros V., Pichard A., Herrmann H.C., Brown D.L., Williams M., Akin J., Davidson M.J., Svensson L.G.; PARTNER 1 Trial Investigators. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2477-84. PMID: 25788234. https://doi.org/10.1016/S0140-6736(15)60308-7
  18. Amat-Santos I.J., Dahou A., Webb J., Dvir D., Dumesnil J.G., Allende R., Ribeiro H.B., Urena M., Paradis J.M., DeLarochellière R., Dumont E., Bergeron S., Thompson C.R., Pasian S., Bilodeau S., Leipsic J., Larose E., Pibarot P., Rodés-Cabau J. Comparison of hemodynamic performance of the balloon-expandable SAPIEN 3 versus SAPIEN XT transcatheter valve. Am J Cardiol. 2014;114(7):1075-82. PMID: 25132330. https://doi.org/10.1016/j.amjcard.2014.07.019
  19. Webb J., Gerosa G., Lefèvre T., Leipsic J., Spence M., Thomas M., Thielmann M., Treede H., Wendler O., Walther T. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 2014;64(21):2235-43. https://doi.org/10.1016/j.jacc.2014.09.026
  20. Unger P., Dedobbeleer C., Vanden Eynden F., Lancellotti P. Mitral regurgitation after transcatheter aortic valve replacement: does the prosthesis matter? Int J Cardiol. 2013;168(2):1706-9. PMID: 23582437. https://doi.org/10.1016/j.ijcard.2013.03.055
  21. Clavel M.A., Webb J.G., Pibarot P., Altwegg L., Dumont E., Thompson C., De Larochellière R., Doyle D., Masson J.B., Bergeron S., Bertrand O.F., Rodés-Cabau J. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol. 2009;53(20):1883-91. PMID: 19442889. https://doi.org/10.1016/j.jacc.2009.01.060
  22. Schultz C.J., Weustink A., Piazza N., Otten A., Mollet N., Krestin G., van Geuns R.J., de Feyter P., Serruys P.W., de Jaegere P. Geometry and degree of apposition of the CoreValve ReValving system with multislice computed tomography after implantation in patients with aortic stenosis. J Am Coll Cardiol. 2009;54(10):911-8. PMID: 19712801. https://doi.org/10.1016/j.jacc.2009.04.075
  23. Giordana F., Capriolo M., Frea S., Marra W.G., Giorgi M., Bergamasco L., Omedè P.L., Sheiban I., D'Amico M., Bovolo V., Salizzoni S., La Torre M., Rinaldi M., Marra S., Gaita F., Morello M. Impact of TAVI on mitral regurgitation: a prospective echocardiographic study. Echocardiography. 2013;30(3):250-7. PMID: 23190425. https://doi.org/10.1111/echo.12050
  24. Wan C.K., Suri R.M,. Li Z., Orszulak T.A., Daly R.C., Schaff H.V. Management of moderate functional mitral regurgitation at the time of aortic valve replacement: is concomitant mitral valve repair necessary? J Thorac Cardiovasc Surg. 2009;137(3):635-40. https://doi.org/10.1016/j.jtcvs.2008.11.015
  25. Unger P., Plein D., Van Camp G., Cosyns B., Pasquet A., Henrard V., de Cannière D., Melot C., Piérard L.A., Lancellotti P. Effects of valve replacement for aortic stenosis on mitral regurgitation. Am J Cardiol. 2008;102(10):1378-82. PMID: 18993159. https://doi.org/10.1016/j.amjcard.2008.07.021
  26. Unger P., Dedobbeleer C., Van Camp G., Plein D., Cosyns B., Lancellotti P. Mitral regurgitation in patients with aortic stenosis undergoing valve replacement. Heart. 2010;96(1):9-14. PMID: 19321488. https://doi.org/10.1136/hrt.2009.165548
  27. Katte F., Franz M., Jung C., Figulla H.R., Leistner D., Jakob P., Stähli B.E., Kretzschmar D., Lauten A. Impact of concomitant mitral regurgitation on transvalvular gradient and flow in severe aortic stenosis: a systematic ex vivo analysis of a subentity of low-flow low-gradient aortic stenosis. EuroIntervention. 2018;13(14):1635-44. PMID: 28994654. https://doi.org/10.4244/EIJ-D-17-00476
  28. Clavel M.A., Burwash I.G., Pibarot P. Cardiac imaging for assessing low-gradient severe aortic stenosis. JACC Cardiovasc Imaging. 2017;10(2):185-202. PMID: 28183438. https://doi.org/10.1016/j.jcmg.2017.01.002
  29. Clavel M.A., Magne J., Pibarot P. Low-gradient aortic stenosis. Eur Heart J. 2016;37(34):2645-57. https://doi.org/10.1093/eurheartj/ehw096
  30. Baumgartner H., Falk V., Bax J.J., De Bonis M., Hamm C., Holm P.J., Iung B, Lancellotti P., Lansac E., Rodriguez Muñoz D., Rosenhek R., Sjögren J., Tornos Mas P., Vahanian A., Walther T., Wendler O., Windecker S., Zamorano J.L.; ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739-91. PMID: 28886619. https://doi.org/10.1093/eurheartj/ehx391
  31. Ong G., Clavel M.A., Pibarot P. Concomitant mitral regurgitation: an insidious cause of lowflow, low-gradient severe aortic stenosis. EuroIntervention. 2018;13(14):1622-5. PMID: 29465404. https://doi.org/10.4244/EIJV13I14A261
  32. Matsumura Y., Gillinov A.M., Toyono M., Oe H., Yamano T., Takasaki K., Saraiva R.M., Shiota T. Echocardiographic predictors for persistent functional mitral regurgitation after aortic valve replacement in patients with aortic valve stenosis. Am J Cardiol. 2010;106:701-6. PMID: 20723649. https://doi.org/10.1016/j.amjcard.2010.04.030
  33. Bedogni F., Latib A., De Marco F., Agnifili M., Oreglia J., Pizzocri S., Latini R.A., Lanotte S., Petronio A.S., De Carlo M., Ettori F., Fiorina C., Poli A., Cirri S., De Servi S., Ramondo A., Tarantini G., Marzocchi A., Fiorilli R., Klugmann S., Ussia G.P., Tamburino C., Maisano F., Brambilla N., Colombo A., Testa L. Interplay between mitral regurgitation and transcatheter aortic valve replacement with the CoreValve Revalving System: a multicenter registry. Circulation. 2013;128(19):2145-53. PMID: 24088530. https://doi.org/10.1161/CIRCULATIONAHA.113.001822
  34. Cribier A., Eltchaninoff H., Bash A., Borenstein N., Tron C., Bauer F., Derumeaux G., Anselme F., Laborde F., Leon M.B. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006-8. PMID: 12473543. https://doi.org/10.1161/01.cir.0000047200.36165.b8
  35. Barbanti M., Webb J.G., Hahn R.T., Feldman T., Boone R.H., Smith C.R., Kodali S., Zajarias A., Thompson C.R., Green P., Babaliaros V., Makkar R.R., Szeto W.Y., Douglas P.S., McAndrew T., Hueter I., Miller D.C., Leon M.B.; Placement of Aortic Transcatheter Valve Trial Investigators. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A. Circulation. 2013;128(25):2776-84. PMID: 24152861. https://doi.org/10.1161/CIRCULATIONAHA.113.003885
  36. Rodes-Cabau J., Webb J.G., Cheung A., Ye J., Dumont E., Feindel C.M., Osten M., Natarajan M.K., Velianou J.L., Martucci G., DeVarennes B., Chisholm R., Peterson M.D., Lichtenstein S.V., Nietlispach F., Doyle D., DeLarochellière R., Teoh K., Chu V., Dancea A., Lachapelle K., Cheema A., Latter D., Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55(11):1080-90. PMID: 20096533. https://doi.org/10.1016/j.jacc.2009.12.014